Filter
7390
Filtered Results: 7390
Text search:
risk
and
impact
management
Featured
Recommendations
687
New Publications
1960
Language
Document type
No document type
4076
Studies & Reports
1315
Guidelines
948
Manuals
393
Strategic & Response Plan
325
Fact sheets
116
Training Material
106
Situation Updates
75
Resource Platforms
16
Infographics
13
Online Courses
4
Brochures
3
Countries / Regions
Global
340
India
253
Kenya
212
Ethiopia
153
Myanmar / Burma
151
Sierra Leone
147
Western and Central Europe
147
Nigeria
145
South Africa
140
Nepal
137
Liberia
136
Uganda
128
Africa
111
Bangladesh
107
Syria
105
Latin America and the Carribbean
101
Tanzania
98
Zambia
97
Malawi
95
Ghana
84
Rwanda
84
Ukraine
82
Congo, Democratic Republic of
66
Philippines
63
South Sudan
61
Eastern Europe
56
Namibia
55
South–East Asia Region
55
Guinea
51
Indonesia
47
Mozambique
46
Asia
46
Lesotho
43
Zimbabwe
40
Haiti
39
Cambodia
39
West and Central Africa
39
Yemen
38
Russia
38
East and Southern Africa
37
Senegal
35
Middle East and North Africa
34
Botswana
32
Afghanistan
31
Brazil
31
Pakistan
29
Burkina Faso
28
Eastern Europe and Central Asia
26
Lebanon
22
Venezuela
21
Sudan
20
Western Pacific Region
20
Cameroon
19
Germany
19
Somalia
18
Jordan
18
Central African Republic
18
Thailand
16
Eswatini/ Swaziland
16
Colombia
16
Mali
15
USA
14
Iraq
13
China
13
Vietnam
13
Turkey
12
Tajikistan
12
Moldova
12
Laos
11
Côte d’Ivoire / Ivory Coast
9
Benin
9
Burundi
9
Sri Lanka
9
Palestine
9
Chad
8
Peru
8
Albania
8
Iran
8
Papua New Guinea
7
Libya
7
Madagascar
7
Chile
7
Georgia
6
Egypt
5
North Macedonia
5
Ecuador
5
Angola
5
Mexico
5
Timor Leste/ East Timor
5
North America
5
Jamaica
5
United Kingdom
5
Guinea-Bissau
4
Niger
4
Togo
4
Gambia
4
Argentina
4
Greece
4
Paraguay
4
Poland
4
Southern Africa
4
Romania
4
Kyrgyzstan
4
Turkmenistan
4
Saudi Arabia
3
Singapore
3
Serbia
3
Hungary
3
Croatia
3
El Salvador
3
Bolivia
3
Fiji
3
Bhutan
3
Armenia
3
Canada
3
Estonia
3
Kazakhstan
3
Japan
3
Mauritius
3
Portugal
3
Spain
3
Belarus
3
Malaysia
2
Vanuatu
2
Honduras
2
Other region
2
North Korea
2
Italy
2
Djibouti
2
Bulgaria
2
France
2
Morocco
1
Mauritania
1
Dominican Republic
1
Guatemala
1
Solomon Islands
1
Mongolia
1
Qatar
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Morocco
1
Azerbaijan
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
2588
Clinical Guidelines
544
Public Health
446
Key Resources
414
Women & Child Health
411
Capacity Building
147
Pharmacy & Technologies
56
Annual Report MEDBOX
3
Toolboxes
COVID-19
658
Mental Health
572
HIV
538
TB
383
Planetary Health
357
Disability
247
Conflict
237
Rapid Response
225
AMR
217
Caregiver
196
Ebola
195
NTDs
170
NCDs
169
Natural Hazards
143
Refugee
140
Global Health Education
131
Pharmacy
100
Health Financing Toolbox
65
Specific Hazards
49
Zika
48
Cholera
44
Polio
43
Social Ethics
19
Typhoon
7
South Sudan
2
Health Financing
2
This report presents key findings from a study carried out on ‘Assessing the effectiveness of targeting mechanisms under PMJAY’. It provides a detailed analysis of potential inclusion and exclusion errors in two select states in India (Haryana <... Uttarakhand) to inform National Health Authority’s (NHA) policy
and approach around beneficiary targeting.
This report presents key findings from a study carried out on the ‘Mainstreaming quality of care in empanelled hospitals under PMJAY’. It provides a detailed analysis of current coverage and perceptions of quality accreditation ... certification across PMJAY empanelled hospitals from three different states
(Haryana, Uttar Pradesh and Gujarat).
In collaboration with partners, the government of Ethiopia has successfully developed 10 years Hand Hygiene for All (HH4A) costed national roadmap- a country-wide approach to achieving sustainable and universal hand hygiene. On the occasion of the 2...
Countries, partners, and donors are committed to
the global elimination of blinding trachoma by 2020.
Achieving this public health milestone requires more
than funding; it requires health personnel with the
right mix of skills, ... well supported and managed
health systems. Mass drug administration (MDA)
with Zithromax®, the Pfizer, Inc. donated antibiotic,
is a key component of the SAFE strategy, endorsed
by the World Health Organization. There is growing
recognition that improving all aspects of MDA, from
planning to training, recording to reporting, and
receipt of drug to distribution (the supply chain), will
be necessary if MDA programmes are going to reduce
the community burden of Chlamydia trachomatis, and
eliminate trachoma as a cause of blindness by 2020.
A key component of elimination is to reduce the number
of unmanaged trachomatous trichiasis cases to less than
1 per 1,000 population in affected areas. This will require
not only a large increase in the number of surgeries
performed, but also improvements in the quality of surgery
... in the efficiency of surgery provision programs. It also
will require that we make special efforts to reach out to
women and the most marginalized populations, who are
disproportionally affected by trichiasis (TT).
The 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic...
In 2019, the Global Fund’s 6th Replenishment raised more than $USD14 billion to fight HIV, Tuberculosis and Malaria. Just two years later, the world has changed significantly. Put simply: COVID-19 devastated prevention ... treatment programs. For the first time since the Global Fund’s founding, in 2020 the world lost ground in the fight against HIV, Tuberculosis and Malaria.
The Global Fund moved quickly to support countries to respond to COVID-19 and its impact on the three diseases, repurposing and leveraging additional funding to support urgent needs and adapt programs. Despite those efforts, the need for action to resume progress in the fight against HIV, TB and malaria has never been greater.
The world faces a choice.
A practical tool for field based humanitarian workers. It provides up-to-date, clear and succint guidance on topics accross the humanitarian sector including references to current, relevant resources and...
This Framework offers a coherent approach for eliminating tuberculosis (TB) in low-incidence countries. It is designed to guide national policy-makers and those responsible for technical aspects of the national TB response in accelerating efforts to...
The Global status report on violence prevention 2014, which reflects data from 133 countries, is the first report of its kind to assess national efforts to address interpersonal violence, namely child maltreatment, youth violence, intimate partner and...
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health ...
At the World Humanitarian Summit in Istanbul in May 2016, leaders made over 3,700 commitments to advance the Agenda for Humanity. In their first self-reports against these commitments, 142 stakeholders described the efforts they made from June to December 2016 to realize this ambitious vision.
The ...
Tuberculosis (TB) control in the African Region has evolved since the disease was declared a global emergency by the World Health Organization (WHO) in 1993. Member States have adopted and implemented successive global ... regional strategies and resolutions, with demonstrable positive impacts on incidence, prevalence and mortality, albeit with variations across countries. By the end of 2015, the Region as a whole met the key Millennium Development Goal (MDG) target of halting and beginning to reverse TB incidence. However only 35 of the 47 Member States met the MDG target.
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals be...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic ne...
The global coronavirus pandemic, which has brought death to hundreds of thousands and serious illness to millions more, also poses profound spiritual questions and real challenges to Christians ever...
3 June 2021. After 40 years of AIDS, charting a course to end the pandemic.
The report shows that countries with progressive laws and policies and strong ... inclusive health systems have had the best outcomes against HIV. In those countries, people living with and affected by HIV are more likely to have access to effective HIV services, including HIV testing, pre-exposure prophylaxis (medicine to prevent HIV), harm reduction, multimonth supplies of HIV treatment and consistent, quality follow-up and care.
Hand hygiene in health care in the context of Filovirus disease outbreak response. Rapid advice guideline
recommended
This document provides a summary of the recommendations for hand hygiene best practices to be performed by health workers providing care and/or support to patients with filovirus infection (Ebola and...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring ... evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicine-related adverse effects in humans, promoting patient safety, and the rational use of medicines. The indicators proposed in this manual are based on the expected functions of pharmacovigilance centres as described in the WHO Mimimum Requirements for a Functional Pharmacovigilance System (1) (see Annex 1 of the manual).
